Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects

Trial Identifier:	PT010010
Sponsor:	Pearl Therapeutics, Inc.
NCTID:	NCT03075267
Start Date:	April 2017
Primary Completion Date:	September 2017
Study Completion Date:	September 2017
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Country	Location
China	Shanghai, China, 200031